Lista de obras - Anna S Berghoff - Dominio Público Uruguay

A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports

artículo científico publicado en 2016

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?

artículo científico publicado en 2014

ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC.

artículo científico publicado en 2014

ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

artículo científico publicado en 2013

Activity of T-DM1 in Her2-positive breast cancer brain metastases

artículo científico publicado en 2015

Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report

artículo científico publicado en 2014

Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer

artículo científico publicado en 2014

Anti-angiogenic therapies in brain metastases.

artículo científico publicado en 2018

Assessing MGMT methylation status and its current impact on treatment in glioblastoma.

artículo científico publicado en 2015

Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease

artículo científico publicado en 2015

BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities.

artículo científico

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

article

Biology in prevention and treatment of brain metastases

artículo científico publicado en 2013

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

scientific article published on 12 November 2018

Brain metastases free survival differs between breast cancer subtypes ⬇️

artículo científico publicado el 10 de enero de 2012

Brain metastases: pathobiology and emerging targeted therapies.

artículo científico publicado en 2012

Brain metastasis: opportunity for drug development?

artículo científico publicado en 2012

Brain tumour cells interconnect to a functional and resistant network

artículo científico publicado en 2015

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.

artículo científico publicado en 2012

Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy.

artículo científico publicado en 2015

Breast cancer brain metastases responding to primary systemic therapy with T-DM1.

artículo científico publicado en 2013

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

scientific article published on 08 July 2020

CECOG educational illustrations: the blood-brain barrier and its relevance for targeted cancer therapies and immuno-oncology.

artículo científico publicado en 2017

CMET-18. EARLY POSTOPERATIVE MRI DETECTS UNEXPECTED RESIDUAL BRAIN METASTASES AFTER RESECTION IN A HIGH FREQUENCY OF CASES: A RETROSPECTIVE ANALYSIS IN THREE SPECIALIZED CENTERS

CMET-26. DIAGNOSTIC VALUE OF FDG-PET/CT FOR PATIENTS WITH BRAIN METASTASIS FROM UNKNOWN PRIMARY SITE

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system.

artículo científico publicado en 2016

Characterization of the inflammatory response to solid cancer metastases in the human brain.

artículo científico publicado en 2012

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

artículo científico publicado en 2018

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers ⬇️

artículo científico publicado el 1 de julio de 2012

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

artículo científico publicado en 2015

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

artículo científico publicado en 2015

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

artículo científico publicado en 2014

Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.

artículo científico publicado en 2014

Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score

artículo científico publicado en 2017

Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

artículo científico publicado en 2013

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

scientific article published on 15 January 2019

Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease

Correlation of immune phenotype with IDH mutation in diffuse glioma.

artículo científico publicado en 2017

Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.

artículo científico publicado en 2017

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

artículo científico publicado en 2015

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

artículo científico publicado en 2016

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study

artículo científico publicado en 2014

Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.

artículo científico publicado en 2018

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

artículo científico publicado en 2015

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

artículo científico publicado en 2018

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?

scientific article published on 01 June 2019

Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns

artículo científico publicado en 2022

Educational video: the role of PD-L1 in the local tumour microenvironment.

artículo científico publicado en 2016

Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor

artículo científico publicado en 2015

Expression of BRAF V600E mutant protein in epithelial ovarian tumors.

artículo científico

Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis.

artículo científico publicado en 2012

Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.

artículo científico publicado en 2015

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

artículo científico publicado en 2012

Genetic variants associated with colorectal brain metastases susceptibility and survival.

artículo científico publicado en 2015

Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.

artículo científico publicado en 2015

High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases

artículo científico publicado en 2018

High plasma-GFAP levels in metastatic myxopapillary ependymoma.

artículo científico publicado en 2013

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

artículo científico publicado en 2013

High-grade meningiomas: new avenues for drug treatment?

artículo científico

Human homologue forCaenorhabditis elegansCUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma ⬇️

artículo científico publicado el 23 de marzo de 2012

IB-02ROLE OF TUMOR INFILTRATING LYMPHOCYTES AND PDL1 EXPRESSION IN GLIOBLASTOMA (GBM) AND BRAIN METASTASES (BM): COMPARATIVE ANALYSIS.

artículo científico publicado en 2014

Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma

artículo científico publicado en 2024

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

artículo científico publicado en 2012

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases

artículo científico publicado en 2016

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

artículo científico publicado en 2013

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo

artículo científico publicado en 2015

In search of a target: PD-1 and PD-L1 profiling across glioma types

artículo científico publicado en 2016

Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.

artículo científico publicado en 2012

Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

artículo científico publicado en 2018

Invasion patterns in brain metastases of solid cancers

scientific article published on 30 September 2013

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

artículo científico publicado en 2015

LAG-3 expression in the inflammatory microenvironment of glioma

artículo científico publicado en 2021

Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy.

artículo científico publicado en 2018

MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases

artículo científico publicado en 2014

NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.

artículo científico publicado en 2013

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases

artículo científico publicado en 2020

New developments in brain metastases

artículo científico publicado en 2018

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations

artículo científico publicado en 2017

O1.03DENSITY OF TUMOR INFILTRATING LYMPHOCYTES CORRELATES WITH BRAIN EDEMA AND OVERALL SURVIVAL IN BRAIN METASTASES.

artículo científico publicado en 2014

O6.02ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA.

artículo científico publicado en 2014

OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas.

artículo científico publicado en 2016

OS7.1 Identification and characterization of brain metastasis initiating cells.

artículo científico publicado en 2016

OS7.3 Impact of platelets and coagulation factors on the early steps of the brain metastatic cascade.

artículo científico publicado en 2016

OS7.4 Outcome of patients presenting with brain metastasis as first manifestation of cancer.

artículo científico publicado en 2016

Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer

scientific article published on 27 March 2012

P02.02PRELIMINARY CHARACTERIZATION OF THE IMMUNE RESPONSE IN GLIOBLASTOMA BEFORE AND AFTER FIRST-LINE THERAPY.

artículo científico publicado en 2014

P04.03 Analysis of the inflammatory tumor microenvironment in meningeal malignancies.

artículo científico publicado en 2016

P04.09 Tumor infiltrating lymphocytes and programmed death ligand 1 (PD-L1) expression in diffuse and anaplastic gliomas

P07.01 18F-fluordesoxyglucose positron emission tomography (FDG-PET) for the detection of the primary lesion in brain metastasis (BM) patients with cancer of unknown primary site (CUPS).

artículo científico publicado en 2016

P08.01RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM).

artículo científico publicado en 2014

P08.54 Revisiting the,,go or grow” hypothesis in glioma in vivo.

artículo científico publicado en 2016

P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS).

artículo científico publicado en 2017

PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome

PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).

artículo científico publicado en 2014

Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer

scientific article published on 17 February 2012

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

artículo científico publicado en 2013

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

scientific article published on 27 August 2019

Prognostic impact of breast cancer subtypes in elderly patients.

artículo científico publicado en 2016

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.

artículo científico publicado en 2014

Psyche at the end of life: Psychiatric symptoms are prevalent in patients admitted to a palliative care unit.

artículo científico publicado en 2015

Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

artículo científico publicado en 2013

Role of the blood-brain barrier in metastatic disease of the central nervous system.

artículo científico publicado en 2018

Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.

artículo científico publicado en 2015

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

scientific article published on 09 July 2018

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.

artículo científico publicado en 2017

Targeted Therapies for Melanoma Brain Metastases

artículo científico publicado en 2017

Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.

artículo científico publicado en 2014

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.

artículo científico publicado en 2018

The PERS(2) ON score for systemic assessment of symptomatology in palliative care: a pilot study

artículo científico publicado en 2015

The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study

scientific article published on 24 May 2018

The future of targeted therapies for brain metastases

artículo científico

The inflammatory microenvironment in brain metastases: potential treatment target?

artículo científico

Toward Precision Medicine in Brain Metastases.

artículo científico publicado en 2018

Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).

artículo científico publicado en 2016

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer

artículo científico publicado en 2016

Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.

artículo científico publicado en 2014

Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma.

artículo científico publicado en 2017

microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells

artículo científico publicado en 2014

αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer

artículo científico publicado en 2014

Lista de obras de Anna S Berghoff

A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?

ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC.

ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.

Activity of T-DM1 in Her2-positive breast cancer brain metastases

Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report

Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer

Anti-angiogenic therapies in brain metastases.

Assessing MGMT methylation status and its current impact on treatment in glioblastoma.

Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease

BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities.

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

Biology in prevention and treatment of brain metastases

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

Brain metastases free survival differs between breast cancer subtypes ⬇️

Brain metastases: pathobiology and emerging targeted therapies.

Brain metastasis: opportunity for drug development?

Brain tumour cells interconnect to a functional and resistant network

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.

Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy.

Breast cancer brain metastases responding to primary systemic therapy with T-DM1.

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

CECOG educational illustrations: the blood-brain barrier and its relevance for targeted cancer therapies and immuno-oncology.

CMET-18. EARLY POSTOPERATIVE MRI DETECTS UNEXPECTED RESIDUAL BRAIN METASTASES AFTER RESECTION IN A HIGH FREQUENCY OF CASES: A RETROSPECTIVE ANALYSIS IN THREE SPECIALIZED CENTERS

CMET-26. DIAGNOSTIC VALUE OF FDG-PET/CT FOR PATIENTS WITH BRAIN METASTASIS FROM UNKNOWN PRIMARY SITE

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system.

Characterization of the inflammatory response to solid cancer metastases in the human brain.

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers ⬇️

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma.

Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.

Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score

Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease

Correlation of immune phenotype with IDH mutation in diffuse glioma.

Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study

Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?

Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns

Educational video: the role of PD-L1 in the local tumour microenvironment.

Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor

Expression of BRAF V600E mutant protein in epithelial ovarian tumors.

Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis.

Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

Genetic variants associated with colorectal brain metastases susceptibility and survival.

Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.

High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases

High plasma-GFAP levels in metastatic myxopapillary ependymoma.

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.

High-grade meningiomas: new avenues for drug treatment?

Human homologue forCaenorhabditis elegansCUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma ⬇️

IB-02ROLE OF TUMOR INFILTRATING LYMPHOCYTES AND PDL1 EXPRESSION IN GLIOBLASTOMA (GBM) AND BRAIN METASTASES (BM): COMPARATIVE ANALYSIS.

Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo

In search of a target: PD-1 and PD-L1 profiling across glioma types

Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.

Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

Invasion patterns in brain metastases of solid cancers

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

LAG-3 expression in the inflammatory microenvironment of glioma

Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy.

MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases

NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases

New developments in brain metastases

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations

O1.03DENSITY OF TUMOR INFILTRATING LYMPHOCYTES CORRELATES WITH BRAIN EDEMA AND OVERALL SURVIVAL IN BRAIN METASTASES.